LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹5.32 Cr | ₹2.84 Cr | ₹6.54 Cr | ₹8.41 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of LASA SUPERGENERICS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹5.32 Cr |
Mar2023 | ₹2.84 Cr |
Mar2022 | ₹6.54 Cr |
Mar2021 | ₹8.41 Cr |
Mar2020 | ₹11 Cr |
How is Total Non-Current Liabilities of LASA SUPERGENERICS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹5.32 Cr | 87.33 | |
Mar2023 | ₹2.84 Cr | -56.54 | |
Mar2022 | ₹6.54 Cr | -22.25 | |
Mar2021 | ₹8.41 Cr | -26.44 | |
Mar2020 | ₹11 Cr | - |
Compare Total Non-Current Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹64.7 Cr | -7% | 41.7% | -52.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -7% |
41.7% |
-52.3% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses